BIO CEO & Investor Conference - Strategic M&A Under Attack: Regulator Resistance and SPAC Competition
New York Marriott Marquis & Virtual
New York, NY 10036
Foley Hoag’s Austin Ownbey will discuss the anti-trust policy climate for biopharma M&A during Biotechnology Innovation Organization’s CEO & Investor Summit on February 15.
Details & registration: https://www.bio.org/events/bio-ceo-investor-conference/sessions/889321